Digital infrastructure provider Applied Digital (NASDAQ:APLD) will be announcing earnings results this Wednesday after market hours. Here’s what to look for. Applied Digital beat analysts’ revenue ...

Applied Digital could outpace Wall Street's expectations when it releases its fiscal 2026 Q2 results. The data center specialist's lease revenue, along with a new contract, should sharply improve its ...

Applied Digital Corporation is moving from a mixed and hard-to-value structure into two focused businesses with clearer roles, funding paths and investor bases. The cloud separation creates a pure AI ...

Applied Digital is making huge progress in building data centers for its clients. Its share price has soared, rising even faster than its quickly growing revenue. The stock's rich valuation -- at ...

Applied Digital is in the right place at the right time as AI spending ramps up. Its ability to achieve projects on time and on budget may help it win over the trust of big tech companies. A single ...

Applied Digital Corp (NASDAQ: APLD) shares are trending on Monday. Here’s a look at what you need to know. What To Know: Applied Digital has shifted its primary focus from hosting Bitcoin mining ...

Applied Digital (APLD) posted $64.2M in Q1 revenue with 84% growth while CoreWeave (CRWV) reported $1.36B in Q3 revenue with 134% growth. CoreWeave generated $51.9M in operating income and doubled its ...

Shares of Applied Digital are rallying, fueled by a strategic investment that positions the high-performance computing center operator at the forefront of next-generation AI infrastructure. A key ...

Seeking Excellent Young Scientists Fund (overseas), Full Professors, Associate Professors, Assistant Professors, Postdoctoral Associate. Job Title: Associate or Senior Editor, Nature Mechanical ...

Applied Materials (AMAT) shares clocked seven straight sessions of gains, as the stock was up 4.2% at $265.38 on Tuesday. The semiconductor materials and equipment company gained 13.7% in the ...

Facing skepticism from analysts about whether it has the resources to take its rare disease drug to market, Applied Therapeutics is laying off almost half of the biotech's workforce to conserve its ...